What is Dysport®?
Prescription Dysport® is an injection used to temporarily improve the look of your moderate to severe frown lines without changing the look of your whole face. The untreated facial muscles still work normally, allowing you to freely show facial expressions, such as smiling, in untreated areas.
Dysport® is a formulation that has been shown to deliver temporary improvement in moderate to severe frown lines, even with repeat treatments. So, the effect of repeat treatment with Dysport® may be comparable to your first use.
How does Dysport® work?
With just 1 injection into each of 5 points between and over the eyebrows, Dysport® blocks the signal from the nerve to the muscles, ultimately resulting in a reduction of muscle activity and temporarily preventing contraction of the muscles that cause frown lines. You should not be treated with Dysport® more frequently than every 90 days.
What causes frown lines?
Over time, repeated movement of the facial skin by the forehead muscles forms lines between the eyebrows. Frown lines are "dynamic" – they happen because of the way a person's face moves.
Are they always related to age?
No. Because frown lines are created by facial movements, such as frowning or squinting, they may develop even in younger adults.
What can you do about them?
Treatment with prescription Dysport® can temporarily improve the look of your moderate to severe frown lines. Treatment generally takes just 10 to 20 minutes.
Clinically proven results with 1 treatment
In 3 clinical studies of people whose frown lines were rated "moderate" or "severe" by a doctor before their treatment with Dysport®:
- 30 days after treatment, the majority (88%, 85%, and 86% in each of the 3 studies) had their frown lines rated by a doctor as "mild" or "moderate" at maximum frown.
- 30 days after treatment, the majority (74%, 79%, and 82% in each of the 3 studies) rated their own frown lines as "mild" or "moderate" at maximum frown.
Used worldwide
Dysport® is used for aesthetic purposes in 36 countries. In the United States, Dysport® was studied for safety in more than 2,400 U.S. patients, and today over 200,000 women and men have been treated with Dysport®.
